PCN97 Cost-Effectiveness of Atezolizumab Monotherapy Versus Pembrolizumab Monotherapy for First-Line Treatment of Metastatic Non-Small Cell Lung Cancer
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI